Emma S Garratt
Overview
    Explore the profile of Emma S Garratt including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              11
            
            
              Citations
              264
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          
        
        
        
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Membrez M, Migliavacca E, Christen S, Yaku K, Trieu J, Lee A, et al.
  
  
    Nat Metab
    . 2024 Mar;
          6(3):433-447.
    
    PMID: 38504132
  
  
          Mitochondrial dysfunction and low nicotinamide adenine dinucleotide (NAD) levels are hallmarks of skeletal muscle ageing and sarcopenia, but it is unclear whether these defects result from local changes or can...
      
2.
        
    
    Burton M, Antoun E, Garratt E, Westbury L, Dennison E, Harvey N, et al.
  
  
    FASEB J
    . 2024 Jan;
          38(3):e23423.
    
    PMID: 38294260
  
  
          Small noncoding RNAs (sncRNAs) are implicated in age-associated pathologies, including sarcopenia and insulin resistance (IR). As potential circulating biomarkers, most studies have focussed on microRNAs (miRNAs), one class of sncRNA....
      
3.
        
    
    Burton M, Garratt E, Hewitt M, Sharkh H, Antoun E, Westbury L, et al.
  
  
    Skelet Muscle
    . 2023 Oct;
          13(1):17.
    
    PMID: 37898813
  
  
          Background: While ageing is associated with increased insulin resistance (IR), the molecular mechanisms underlying increased IR in the muscle, the primary organ for glucose clearance, have yet to be elucidated...
      
4.
        
    
    Burton M, Antoun E, Garratt E, Westbury L, Baczynska A, Dennison E, et al.
  
  
    J Cachexia Sarcopenia Muscle
    . 2023 May;
          14(4):1762-1774.
    
    PMID: 37199333
  
  
          Background: Amongst healthy older people, a number of correlates of impaired skeletal muscle mass and function have been defined. Although the prevalence of obesity is increasing markedly in this age...
      
5.
        
    
    Antoun E, Garratt E, Taddei A, Burton M, Barton S, Titcombe P, et al.
  
  
    J Cachexia Sarcopenia Muscle
    . 2021 Dec;
          13(1):240-253.
    
    PMID: 34862756
  
  
          Background: Sarcopenia is the age-related loss of muscle mass, strength, and function. Epigenetic processes such as DNA methylation, which integrate both genetic and environmental exposures, have been suggested to contribute...
      
6.
        
    
    Antoun E, Kitaba N, Titcombe P, Dalrymple K, Garratt E, Barton S, et al.
  
  
    PLoS Med
    . 2020 Nov;
          17(11):e1003229.
    
    PMID: 33151971
  
  
          Background: Higher maternal plasma glucose (PG) concentrations, even below gestational diabetes mellitus (GDM) thresholds, are associated with adverse offspring outcomes, with DNA methylation proposed as a mediating mechanism. Here, we...
      
7.
        
    
    Migliavacca E, Tay S, Patel H, Sonntag T, Civiletto G, McFarlane C, et al.
  
  
    Nat Commun
    . 2019 Dec;
          10(1):5808.
    
    PMID: 31862890
  
  
          The causes of impaired skeletal muscle mass and strength during aging are well-studied in healthy populations. Less is known on pathological age-related muscle wasting and weakness termed sarcopenia, which directly...
      
8.
        
    Differential SLC6A4 methylation: a predictive epigenetic marker of adiposity from birth to adulthood
  
  
    
    Lillycrop K, Garratt E, Titcombe P, Melton P, Murray R, Barton S, et al.
  
  
    Int J Obes (Lond)
    . 2019 Jan;
          43(5):974-988.
    
    PMID: 30622309
  
  
          Background: The early life environment may influence susceptibility to obesity and metabolic disease in later life through epigenetic processes. SLC6A4 is an important mediator of serotonin bioavailability, and has a...
      
9.
        
    
    Lillycrop K, Costello P, Teh A, Murray R, Clarke-Harris R, Barton S, et al.
  
  
    Int J Epidemiol
    . 2015 Apr;
          44(4):1263-76.
    
    PMID: 25906782
  
  
          Background: Early life environments induce long-term changes in neurocognitive development and behaviour. In animal models, early environmental cues affect neuropsychological phenotypes via epigenetic processes but, as yet, there is little...
      
10.
        
    
    Garratt E, Vickers M, Gluckman P, Hanson M, Burdge G, Lillycrop K
  
  
    PLoS One
    . 2013 Jul;
          8(6):e67483.
    
    PMID: 23825665
  
  
          The genes encoding nuclear receptors comprise multiple 5'untranslated exons, which give rise to several transcripts encoding the same protein, allowing tissue-specific regulation of expression. Both human and mouse peroxisome proliferator...